Skip to main content
Equibles

PLRZ · Polyrizon Ltd.

Track PLRZ — free

Use PLRZ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PLRZ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.32 +0.29 (+2.63%)
Rebalance outlook locked
Market Cap
$26.16M
Shares
2.37M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$11.03 Open$11.19 Day$10.50–11.36 Since split$3.16–17.17 Avg vol 30d86K Short int69K · 2.9% float · 1.0d Short vol81% DataNov 2025–Sep 2026

Raw chart and full-history price indicators begin at the captured split on Nov 28, 2025; bars on opposite sides are not compared.

The closing range begins at the captured split on Nov 28, 2025.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
2.9%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Neutral Sentiment Neutral Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −10%
below
RSI (14) 45
neutral
MACD trend Negative
52-week position 56%
mid-range
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Neutral
1-month return +3%
trailing
6-month return −19%
trailing
YTD return +30%
this year
Relative strength −37%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.89% of float · ▼ -27.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
4 holders — mid 1-yr range
Squeeze score 44
elevated · 0–100
Fundamentals
Poor
EPS growth −99%
Y/Y
Free cash flow $-4.5M
Quant / Vol
risk profile
Very High
Volatility 226%
annualized · 1-yr
Max drawdown −50%
past year
ATR 12.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−10% Bearish
RSI (14)
45 Neutral
MACD trend
Negative Bearish
52-week position
56% Neutral
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.89% of float · ▼ -27.2% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
4 holders — mid 1-yr range
Price context
position in its range since split · 2025-11-28
Range low $3 Now $11 · 56% Range high $17
vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PLRZ
Polyrizon Ltd.
this stock
$26.16M +29.9% — — 2.9%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.64B +13.7% +46.2% 30.0 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.46B +1.2% +20.8% 19.4 2.5%
ARGX
Argenx SE
 $61.87B +17.1% — — 2.0%
CSLLY
Csl Ltd
 $58.97B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
4
% held
9.3%
Net QoQ
+185.0K sh
Top holder
MMCAP International Inc.…
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
68.6K
Days to cover
1.0d
Change
-25.7K sh
View
Short Volume
Short vol %
81%
As of
Sep 14, 2026
Short Total
View
Fails to Deliver
FTD shares
10.1K
Value
$110.0K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
60.1%
Week of
Aug 10, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-3.3M
EPS diluted
$4.90
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 4, 2026
This year
27
View
Exempt Offerings
Offering
$4.0M
Filed
Sep 10, 2026
View

Performance

Raw-price comparisons begin at the captured split on Nov 28, 2025; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
PLRZ -12.2% +2.6% -19.5% -24.0% +29.9%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -11.0% +4.4% -37.3% -23.6% +17.8%
Key facts CIK 1893645 CUSIP M79549206 Visit website Investor relations